Curis (CRIS) CEO receives 110,090 employee stock options at $5.29

Filing Impact

(Very High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CURIS INC President & CEO James E. Dentzer reported a compensation-related grant of employee stock options. He was awarded options to buy 110,090 shares of Curis common stock at an exercise price of $5.29 per share, expiring on July 6, 2036.

According to the filing, 25% of the original option shares vest on July 7, 2027, with an additional 6.25% of the original shares vesting each successive quarter until July 7, 2030. Following this grant, Dentzer holds options covering 110,090 underlying shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dentzer James E

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	Employee stock option (right to buy)	110,090	$5.29	$582K

Holdings After Transaction: Employee stock option (right to buy) — 110,090 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 110,090 shares Exercise price: $5.29 per share Underlying shares: 110,090 shares +4 more

7 metrics

Option grant size 110,090 shares Employee stock option covering Curis common stock

Exercise price $5.29 per share Conversion or exercise price of the option

Underlying shares 110,090 shares Common stock underlying the employee stock option

Post-grant option holdings 110,090 derivative shares Total shares following transaction in the Form 4

Initial vesting portion 25% of original shares Vests on July 7, 2027 per footnote

Quarterly vesting portion 6.25% of original shares Vests each successive quarter until July 7, 2030

Option expiration July 6, 2036 Expiration date of the employee stock option

Key Terms

Employee stock option (right to buy), Common Stock, conversion or exercise price, vests, +1 more

5 terms

Employee stock option (right to buy) financial

"security_title: Employee stock option (right to buy)"

Common Stock financial

"underlying_security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

conversion or exercise price financial

"conversion_or_exercise_price: 5.2900"

vests financial

"The option grant described in this Form 4 filing vests as to 25% of the original shares"

expiration date financial

"expiration_date: 2036-07-06T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 04:10 PM Accepted by SEC EDGAR 07/09/2026 - 04:09 PM

FAQ

What did Curis (CRIS) President & CEO James E. Dentzer report on this Form 4?

James E. Dentzer reported receiving an employee stock option grant. The award covers 110,090 underlying shares of Curis common stock as a compensation-related grant, not an open-market purchase or sale, and is held directly according to the Form 4 details.

How many Curis (CRIS) shares are covered by the new option grant?

The new option grant covers 110,090 underlying shares of Curis common stock. This figure is explicitly listed as both the number of option shares granted and the number of underlying common shares tied to the derivative security in the Form 4.

What is the exercise price and expiration date of the Curis (CRIS) CEO’s stock options?

The options have an exercise price of $5.29 per share and expire on July 6, 2036. These terms define the price Dentzer must pay to buy shares and the final date the options can be exercised.

How do the newly granted Curis (CRIS) options vest for the CEO?

The option vests 25% of the original shares on July 7, 2027. An additional 6.25% of the original shares then vest each successive quarter until July 7, 2030, gradually making the entire grant exercisable over time.

Is this Curis (CRIS) Form 4 an open-market stock purchase or sale?

No, this Form 4 reports a grant of employee stock options, not an open-market trade. The transaction code is “A” for a grant or award, reflecting compensation rather than a discretionary buy or sell in the market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dentzer James E

(Last)

(First)

(Middle)

128 SPRING STREET

BUILDING C - SUITE 500

(Street)

LEXINGTON

MASSACHUSETTS

02421

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURIS INC [ CRIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee stock option (right to buy)	$5.29	07/07/2026		A		110,090		⁽¹⁾	07/06/2036	Common Stock	110,090	$5.29	110,090	D

Explanation of Responses:

1. The option grant described in this Form 4 filing vests as to 25% of the original shares on July 7, 2027 and as to an additional 6.25% of the original shares each successive quarter and until July 7, 2030.

Remarks:

Exhibit Index: 24.1 Power of Attorney

	/s/ Diantha Duvall, Attorney-in-fact	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR